Compare EMBJ & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBJ | ELAN |
|---|---|---|
| Founded | 1969 | 1954 |
| Country | Brazil | United States |
| Employees | 25037 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 12.4B |
| IPO Year | N/A | 2018 |
| Metric | EMBJ | ELAN |
|---|---|---|
| Price | $64.83 | $24.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $84.00 | $27.89 |
| AVG Volume (30 Days) | 881.4K | ★ 3.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | N/A | $8.21 |
| Revenue Next Year | $13.60 | $5.31 |
| P/E Ratio | ★ $159.30 | $225.27 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $53.56 | $13.39 |
| 52 Week High | $80.75 | $27.72 |
| Indicator | EMBJ | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 51.39 |
| Support Level | $60.05 | $23.56 |
| Resistance Level | $66.25 | $25.35 |
| Average True Range (ATR) | 1.60 | 0.88 |
| MACD | -0.13 | -0.09 |
| Stochastic Oscillator | 58.33 | 44.99 |
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment. Geographically, the company operates in Brazil, Europe, Asia Pacific, North America, and Others.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.